Terms: = Head and neck cancer AND FLCN, BHD, 201163, ENSG00000154803, MGC23445, MGC17998, FLCL AND Treatment
4 results:
1. Germline- and Somatic-Inactivating flcn Variants in Parathyroid cancer and Atypical Parathyroid Tumors.
Jha S; Welch J; Tora R; Lack J; Warner A; Del Rivero J; Sadowski SM; Nilubol N; Schmidt LS; Linehan WM; Weinstein LS; Simonds WF; Agarwal SK
J Clin Endocrinol Metab; 2023 Sep; 108(10):2686-2698. PubMed ID: 36935552
[TBL] [Abstract] [Full Text] [Related]
2. Successful treatment of facial papules with electrodessication in a patient with Birt-Hogg-Dubé syndrome.
Pritchard SE; Mahmoudizad R; Parekh PK
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046466
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (flcn).
Lu X; Boora U; Seabra L; Rabai EM; Fenton J; Reiman A; Nagy Z; Maher ER
Oncogene; 2014 Feb; 33(8):956-65. PubMed ID: 23416984
[TBL] [Abstract] [Full Text] [Related]
4. Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma. A Southwest Oncology Group study.
Costanzi JJ; Fletcher WS; Balcerzak SP; Taylor S; Eyre HJ; O'Bryan RM; Al-Sarraf M; Frank J
Cancer; 1984 Feb; 53(4):833-6. PubMed ID: 6362830
[TBL] [Abstract] [Full Text] [Related]
